Aoxing Pharmaceutical Comp. Inc. (AOXG)

[JJSeabrook]

Aoxing Pharma Gains Inclusion of Zhongtongan in Procurement Lists of Hebei, Jiangsu, Shanxi, and Hubei Provinces
Accesswire
7 hours ago

????

JERSEY CITY, NJ / ACCESSWIRE / September 16, 2015 / Aoxing Pharmaceutical Company, Inc. (NYSE MKT: AXN) ("Aoxing Pharma"), a specialty pharmaceutical company focusing on research, development, manufacturing, and distribution of narcotic, pain-management, and addiction treatment pharmaceuticals, today announced that its best-selling product, Zhongtongan (an herbal extract capsule for toothache, stomatitis, bone and joint pain treatment), has been included in the government essential drug procurement lists for Hebei, Jiangsu, Shanxi, and Hubei Provinces. Hebei Province has begun procurement of the drug, and the Company expects Jiangsu, Shanxi, and Hubei Provinces will begin procurement soon.

"We're very excited that Zhongtongan has been recognized as an essential drug in four additional provinces," said Mr. Zhenjiang Yue, Chairman and CEO of Aoxing Pharma. "This reaffirms the quality and acceptance of our products. Sales in those four provinces, which have a combined population of 220 million, already account for 30% of the Company's total sales. We expect government procurement to increase over time, which should cause Zhongtongan sales in the four provinces to increase several fold."

The inclusion of Zhongtongan in the provincial drug procurement lists is part of an overall strategy by Aoxing Pharma to take advantage of China's increasing drug reimbursement in connection with its move to universal healthcare. The Company is also working on obtaining inclusion of Zhongtongan and other products in the New Rural Cooperative Medical System, which would add the nation's rural population to the Company's market.

Meanwhile, the package design and other preparations for our newly approved product, Tilidine, have been completed. The Company expects to commence a national rollout with initial production and sales in the quarter ended December 31, 2015.

We are currently estimating the effect of the above on our revenue and profitability. The Company plans to provide financial guidance at the same time we report out fiscal 2015 results at the end of this month.

About Aoxing Pharmaceutical Company, Inc.

Aoxing Pharmaceutical Company, Inc. is a US incorporated specialty pharmaceutical company with its operations in China, specializing in research, development, manufacturing and distribution of a variety of narcotics and pain-management products. Headquartered in Shijiazhuang City, outside Beijing, Aoxing Pharma has the largest and most advanced manufacturing facility in China for highly regulated narcotic medicines. Its facility is one of the few GMP facilities licensed for the manufacture of narcotic medicines by the China Food and Drug Administration ("CFDA"). For more information, please visit: www.aoxingpharma.com.

Safe Harbor Statement from Aoxing Pharmaceutical Company, Inc.

Certain statements made in this press release are forward-looking and are made pursuant to the safe harbor provisions of the Securities Litigation Reform Act of 1995. Such statements involve risks and uncertainties that may cause actual results to differ materially from those set forth in these statements. All forward-looking statements included herein are based upon information available to the Company as of the date hereof and, except as is expressly required by the federal securities laws, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, changed circumstances or future events or for any other reason. To the extent that any statements made here are not historical, these statements are essentially forward-looking. Undue reliance should not be placed on forward-looking information. The economic, competitive, governmental, technological and other risk factors identified in the Company's filings with the Securities and Exchange Commission, specifically, Item 1A, "Risk Factors," in the Form 10-K for the year ended June 30, 2014, may cause actual results or events to differ materially from those described in the forward looking statements in this press release. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise.

CONTACT:

Aoxing Pharmaceutical Company:
646-367-1747
[e-mail]

SOURCE: Aoxing Pharmaceutical Company, Inc.

[PennyWorld]

Back into AXN again. Took $900 in profits in July and getting back on based on the last positive PR regarding clinical trials. Anyone here following this stock? The last post is rather dated.

[onthelak42]

http://finance.yahoo.com/news/aoxing-pharma-announces-positive-results-123700229.html
JERSEY CITY, NJ / ACCESSWIRE / July 13, 2015 / Aoxing Pharmaceutical Company, Inc. (NYSE MKT: AXN) ("Aoxing Pharma"), a specialty pharmaceutical company focusing on research, development, manufacturing, ...

[JJSeabrook]

Aoxing Pharmaceutical Company, Inc. Granted Certification of High and New-Technology Enterprise
Accesswire
1 hour ago

????

JERSEY CITY, NJ / ACCESSWIRE / June 29, 2015 / Aoxing Pharmaceutical Company, Inc. (NYSE MKT: AXN) ("Aoxing Pharma" or the "Company"), a specialty pharmaceutical company focusing on research, development, manufacturing, and distribution of narcotic, pain-management, and addiction treatment pharmaceuticals, today announced that the Company has been granted certification as a High and New Technology Enterprise ("HNTE"), jointly issued by the Hebei Department of Science and Technology, Hebei Department of Finance and Hebei State Tax Bureau. Under China's HNTE Program, eligible enterprises enjoy a 15% preferential corporate income tax rate instead of the standard 25% rate. HNTE status is renewable three years after certificate issuance. Three years after certificate renewal, the recipient may reapply for continued certification.

Zhenjiang Yue, CEO of Aoxing Pharma, commented, "We are pleased to receive the certification of High and New Technology Enterprise. This is a testament to our continued dedication to research and technology development, and an acknowledgment of our portfolio of patents and intellectual property. The preferential tax treatment will allow the Company to further amplify profitability as we launch new products."

About Aoxing Pharmaceutical Company, Inc.

Aoxing Pharmaceutical Company, Inc. is a US incorporated specialty pharmaceutical company with its operations in China, specializing in research, development, manufacturing and distribution of a variety of narcotics and pain-management products. Headquartered in Shijiazhuang City, outside Beijing, Aoxing has the largest and most advanced manufacturing facility in China for highly regulated narcotic medicines. Its facility is one of the few GMP facilities licensed for the manufacture of narcotic medicines by the China Food and Drug Administration (CFDA). For more information, please visit: www.aoxingpharma.com.

Safe Harbor Statement from Aoxing Pharmaceutical Company, Inc.

Certain statements made in this press release are forward-looking and are made pursuant to the safe harbor provisions of the Securities Litigation Reform Act of 1995. Such statements involve risks and uncertainties that may cause actual results to differ materially from those set forth in these statements. All forward-looking statements included herein are based upon information available to the Company as of the date hereof and, except as is expressly required by the federal securities laws, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, changed circumstances or future events or for any other reason. To the extent that any statements made here are not historical, these statements are essentially forward-looking. Undue reliance should not be placed on forward-looking information. The economic, competitive, governmental, technological and other risk factors identified in the Company's filings with the Securities and Exchange Commission, specifically, Item 1A, "Risk Factors," in the Form 10-K for the year ended June 30, 2014, may cause actual results or events to differ materially from those described in the forward looking statements in this press release. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise.

CONTACT:

Aoxing Pharmaceutical Company:
646-367-1747
[e-mail]

SOURCE: Aoxing Pharmaceutical Company, Inc.

[Drewjamessb]

Greece will keep this from climbing but it will slowly bounce back in time even with the new shelf. Will take more at 1.80s in the morning.

[onthelak42]

50 ml more shares possible plus just under 70 ml = under 120 ml. Add some to the 38 ml float, still not very bad. jmo

[Shotor]

Its all good
We close green

[JJSeabrook]

S-3 filing.

[Shotor]

Why down?

[JJSeabrook]

Awesome close right at HOD today. Strong day!!


AXN

[Drewjamessb]

Bottom in. Time to work back up after this consolidation:)

[zeroknowledgeproof]

Bovine Excrement.

No other way to describe it.

[zeroknowledgeproof]

Slow grind down to sub dollar.

[Smm70]

China daily.com.cn - 277,000 pharmacies in 2013!


2015....maybe more?

[Smm70]

Google -2013 stats I think?

[Cashpen]

Where did you get those #s from?

[Smm70]

Consider this...29.000 hospitals and 221.000 pharmacies are being notified about Tilidine by Aoxing.

I'd say those are good odds.

[zeroknowledgeproof]

Seems like a PUMP and DUMP?

I mean just look at the chart.

[zeroknowledgeproof]

If you don't take the money someone else will.

The stock market is THE MOST DANGEROUS place to have your money. There are super computers running 24/7 looking to harvest YOUR money. They WILL find you and play you.

[Smm70]

Note to self - when you sit on close to 100% profit after only a few weeks, sell 1/2 of your holdings into strength and park it for the inevitable retraction.

I need to remember that!

Stabilizing around 2.40 at 1/7th of the volume yesterday. All healthy so far.

[JJSeabrook]

Would have preferred an interview of the CEO or COO rather than the CFO.

[Want2BMillionaire]

Yes, maybe AH today.

[JJSeabrook]

Now someone that was there needs to come out with a write-up! May still be coming, and hopefully from several. We'll see.

[Want2BMillionaire]

Indeed!! Thanks...

[JJSeabrook]

Only a few empty seats at the Press/Investor Conference.

http://charts.stocktwits.com/production/original_38076856.jpg?1433953477

http://charts.stocktwits.com/production/original_38076791.jpg?1433953438

Good to see!

AXN

[Want2BMillionaire]

Well the video was ok, but honestly, IMO, it's not that spectacular with how they made the pr sound regarding multiple updates....They could have just put the pr out and not had to do such a big conference... Again, hopefully there is more major news to announce shortly..

[Want2BMillionaire]

Ooh, cool, thanks....

[Want2BMillionaire]

Got That right!!! AXN is tanking and the shorts are having a field day.... This is such BS!! Hopefully, maybe they are finalizing some details about a possible partnering/merger/buyout??

[JJSeabrook]

AXN CEO interview at NYSE

[JJSeabrook]

Don't know, but wish they would PR it soon, as in NOW. LOL

[Want2BMillionaire]

Hey JJ... What I don't understand is that in the initial pr on Monday, they said they will release UPDATES, (plural) and including the project regarding of 10 years, they only release about the 10 yr project???? What else was discussed in conference?? Any thoughts?

[JJSeabrook]

Aoxing gets OK to make narcotic pain reliever
Updated: 2015-06-10 11:12
By Niu Yue in New York(China Daily USA)
Print Mail Large Medium Small
0

Five years after listing its shares on the New York Stock Exchange, Aoxing Pharmaceutical Co Inc visited the NYSE again, its CEO announcing that it had been granted a license to produce a narcotic pain reliever in China.

Aoxing announced on Monday that it had received approval from the China Food and Drug Administration (CFDA) to make tilidine hydrochloride tablets.

"This is a significant milestone achievement in the business development of Aoxing Pharma," CEO Yue Zhenjiang said at the NYSE on Tuesday. "Tilidine is less addictive and works well on reliving pain. What's more, it's the first time it's being produced in China."

In a statement on Monday, Yue said that "this approval is the culmination of 12 years of research, development and regulatory activities. Our entry into the market will be a significant breakthrough in China's fight to treat pain. Our Tilidine HCL tablets offer a convenient medium for delivery of this drug."

He said that a report published by the World Health Organization in 1985 made him realize the great potential of the pain-relief market in China.

According to a 2000 WHO survey, the amount of per capita narcotic consumption in China was less than 1% of that in North America, because Chinese people hadn't realized that relieving pain could improve both their physical and mental health, and research and production are forbidden without approval.

Aoxing, established in Shijiazhuang in 2000, acquired permission in 2002 to enter the narcotics market in China.

Other Aoxing drugs, like an oxycodone tablet and naloxone sublingual tablet have already completed clinical trials, and the company expects them to be licensed in China in the next year or two.

Yue said that the current government has raised pain-management treatment to the level of a human right. A new policy on guaranteeing treatment for patients suffering from pain while strictly prohibiting the abuse of controlled substances has been introduced recently.

With an increase in reimbursement from the new medical insurance and the new Rural Medical Cooperative System, as well as the significant improvement of people's living standards, "the demand for narcotic medicines in China will be increasing over 30 percent yearly", Yue said.

Aoxing has 137 products, many of them best-selling pain-relievers.

Shares of Aoxing, which trades under the symbol AXN, closed at $2.67, down 11 cents, in NYSE trading on Tuesday.

Hong Xiao in New York contributed to this story.

http://usa.chinadaily.com.cn/epaper/2015-06/10/content_20959207.htm

[Want2BMillionaire]

Hopefully they are waiting to release an explosive pr at 9:30 when market opens so they can F**K all the SHORTS........

[Smm70]

Cashpen thanks! Just did....yet nothing on their website, no PR....that, in itself, is giving enough downside pressure imo.

[Cashpen]

Check out stocktwits $AXN, lots of posts on the news conference that did in fact take place, set for take off PM huge upside, last nights AH sell off was only a panic

[Smm70]

Has anyone seen any news about the conference call? Did it take place? $30m shares traded in 2 days....wth?

[Cashpen]

In all seriousness, it could have been a deal they were trying to iron out the details before the release the news but couldn't finalize?

[Cashpen]

Chinese pump and dump, it's the opposite of Us dumb Americans...they dump THEN pump...makes more sense anyway if you think about it. News to come in pre-market then blastoff

[stmichael4]

They are having sushi with ABAT. LOL

[Cashpen]

So there was no news conference?

[zeroknowledgeproof]

Margin Call.

Best movie about wall street ever.

[srvguitar]

Someone should go to jail. Dirty play after hours

[castisos]

As soon as you post it drops lol

[zeroknowledgeproof]

Beginning of a fire sale?

Is this what the beginning of a fire sale looks like?

[ClayTrader]

* * $AXN Video Chart 06-09-15 * *

Link to Video - click here to watch the technical chart video

[Drewjamessb]

Anyone have a summary of this conference call? I heard it was all in Chinese. Hmm

[wickerman]

AXN that's what I'm thinking too, had a nice trade selling the gap up from my $2.55 buy yesterday then got back in at $2.94 and gave some back oh well

[zeroknowledgeproof]

Poignant

Wisdom @3:35

[zeroknowledgeproof]

Clint Eastwood trading.

So you gotta ask yourself do you feel lucky?

Well do ya? Punk.

$2.50, then $1.80, then 1.60, then ... sheesh no one will care at that point.

[zeroknowledgeproof]

Don't worry Upham to the rescue.